The Pennant Group, Inc.

NASDAQ:PNTG

Medical - Care Facilities

Healthcare
$35.81 -2.41%

-$0.83 today

Market cap
$1.26B
Beta
1.27
P/E (TTM)
38.6
EPS (TTM)
$0.87
52W Low $21.73High $37.54

Volume 0.43M

Average 0.25M

PNTG Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

The Pennant Group, Inc.NASDAQ: PNTG

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development remains negative

Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMMar 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How PNTG compares with its peers on the latest reported figures

  • PNTG's LTM Mar 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
  • Research & development amounts to 0.0% of revenue for PNTG, versus a peer median of 0.0%.
PNTG Competitors Peer median
Research & Development for PNTG and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PNTGThe Pennant Group, Inc.LTM Mar 2026$0 ——0.0%
EHCEncompass Health CorporationLTM Jun 2026$0 ——0.0%
ENSGThe Ensign Group, Inc.LTM Jun 2026$0 ——0.0%
PACSPACS Group, Inc.LTM Jun 2026$0 ——0.0%
CHEChemed CorporationLTM Jun 2026$0 ——0.0%
NHCNational HealthCare CorporationLTM Sep 2026$0 ——0.0%
AVAHAveanna Healthcare Holdings Inc.LTM Oct 2026$0 ——0.0%
ADUSAddus HomeCare CorporationLTM Jun 2026$0 ——0.0%
BKDBrookdale Senior Living Inc.LTM Sep 2026$0 ——0.0%
SNDASonida Senior Living, Inc.LTM Mar 2026$0 ——0.0%
INNVInnovAge Holding Corp.LTM Mar 2026$0 ——0.0%
Peer median (excluding PNTG) $0——0.0%

Competitors are the stored peer set for PNTG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue439.69M473.24M544.89M695.24M947.71M
Cost of Revenue391.1M414.66M477.86M601.48M825.24M
Gross Profit48.6M58.59M67.04M93.76M122.47M
Gross Margin11.1%12.4%12.3%13.5%12.9%
Research & Development00000
Selling, General & Admin36.26M33.98M36.67M50.21M71.08M
Operating Expenses43.9M45.85M41.87M55.65M71.08M
Depreciation & Amortization4.78M4.9M5.13M6.12M8.54M
EBITDA9.46M17.61M30.64M44.44M60.85M
EBITDA Margin2.2%3.7%5.6%6.4%6.4%
Operating Income4.7M12.74M25.17M38.12M51.39M
Operating Margin1.1%2.7%4.6%5.5%5.4%
Interest Income00000
Interest Expense1.94M3.82M5.92M6.96M6.68M
Other Income / Expenses(1.97M)(3.85M)(5.59M)(6.75M)(5.76M)
Income Before Tax2.73M8.89M19.58M31.37M45.63M
Pre-Tax Margin0.6%1.9%3.6%4.5%4.8%
Income Tax Expense582K1.65M5.67M7.03M11.87M
Net Income2.7M6.64M13.38M22.56M29.58M
Net Margin0.6%1.4%2.5%3.2%3.1%
EPS (Basic)0.080.230.450.720.86
EPS (Diluted)0.070.220.440.710.84
Weighted Avg Shares28.41M29.06M29.86M31.19M34.56M
Weighted Avg Shares (Diluted)30.64M30.16M30.19M32M35.32M

The Pennant Group, Inc.

NASDAQ:PNTG

Intrinsic Alpha fair value

Locked

Current Price

$35.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.